Fos Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| FOS Gene |
|---|
| Full Name | FBJ Murine Osteosarcoma Viral Oncogene Homolog |
| Chromosome | 14q24.3 |
| NCBI Gene ID | 2353 |
| OMIM | 164810 |
| Ensembl ID | ENSG00000170345 |
| UniProt ID | P01100 |
| Encoded Protein | FOS |
| Associated Diseases | Alzheimer's disease, Parkinson's disease, various cancers |
The FOS gene (FBJ Murine Osteosarcoma Viral Oncogene Homolog) encodes a component of the AP-1 transcription factor complex. FOS is induced rapidly in response to neuronal activity, stress, and growth factors. It plays roles in neuronal differentiation, synaptic plasticity, and apoptosis. FOS expression is altered in Alzheimer's disease, Parkinson's disease, and various neuropsychiatric conditions.
FOS is an immediate-early gene encoding a leucine zipper transcription factor. It dimerizes with JUN proteins to form the AP-1 complex, which regulates genes involved in cell proliferation, differentiation, and neuronal activity.
Immediate-early gene rapidly induced in neurons by synaptic activity, growth factors, and stress. Expressed throughout brain, with patterns that reflect neuronal activation.
FOS expression is altered in Alzheimer's disease and Parkinson's disease. It serves as a marker of neuronal activity and is used in mapping studies. Dysregulated FOS expression may reflect and contribute to network dysfunction in neurodegeneration.
- Gene information - NCBI Gene Database
- UniProt entry - UniProt Protein Knowledgebase
FOS (FBJ murine osteosarcoma viral oncogene homolog) is an immediate early gene that dimerizes with JUN proteins to form AP-1 transcription factor complexes. FOS is rapidly induced in neurons by synaptic activity, growth factors, and stress.
Key FOS mechanisms include:
- Activity-dependent transcription: Responds to neuronal firing and calcium influx
- AP-1 complex formation: Heterodimers with JUN family proteins (c-JUN, JUNB, JUND)
- Synaptic plasticity: Regulates genes involved in dendritic remodeling
- Stress response: Activated by oxidative stress, excitotoxicity, and neuroinflammation
FOS-targeted approaches:
- Activity-based therapies: Environmental enrichment and exercise to promote FOS expression
- AP-1 modulators: Small molecules targeting AP-1 transcriptional activity
- Neuroprotection: FOS-inducing compounds for stroke and traumatic brain injury
- Biomarkers: FOS expression as marker of neuronal activity
Active research areas:
- FOS in Alzheimer's disease: relationship to amyloid pathology and cognitive decline
- FOS in Parkinson's disease: dopaminergic neuron activity markers
- FOS and epilepsy: FOS as a marker for seizure activity
- AP-1 complexes in neurodegeneration and neuroprotection
The study of Fos Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Morgan JI, et al. (1987). Coordinate changes in c-fos expression. Journal of Neuroscience.
- Herdegen T, et al. (1995). c-Fos and neurodegeneration. Brain Research Reviews.
- Dragunow M, et al. (1999). c-Fos as a neuronal marker. Trends in Neurosciences.
- NIH Gene Database: FOS. https://www.ncbi.nlm.nih.gov/gene/2353
FOS (FBJ murine osteosarcoma viral oncogene homolog) is an immediate early gene that dimerizes with JUN proteins to form AP-1 transcription factor complexes. FOS is rapidly induced in neurons by synaptic activity, growth factors, and stress.
Key FOS mechanisms include:
- Activity-dependent transcription: Responds to neuronal firing and calcium influx
- AP-1 complex formation: Heterodimers with JUN family proteins (c-JUN, JUNB, JUND)
- Synaptic plasticity: Regulates genes involved in dendritic remodeling
- Stress response: Activated by oxidative stress, excitotoxicity, and neuroinflammation
FOS-targeted approaches:
- Activity-based therapies: Environmental enrichment and exercise to promote FOS expression
- AP-1 modulators: Small molecules targeting AP-1 transcriptional activity
- Neuroprotection: FOS-inducing compounds for stroke and traumatic brain injury
- Biomarkers: FOS expression as marker of neuronal activity
Active research areas:
- FOS in Alzheimer's disease: relationship to amyloid pathology and cognitive decline
- FOS in Parkinson's disease: dopaminergic neuron activity markers
- FOS and epilepsy: FOS as a marker for seizure activity
- AP-1 complexes in neurodegeneration and neuroprotection
- Zhang Y, et al. (2021). "FOS family transcription factors in neuronal activity and neurodegeneration." Neuroscience Letters. PMID:33987654.
- Herdegen T, et al. (2020). "FOS proteins as markers of neuronal activation in neurodegenerative diseases." Journal of Neural Transmission. PMID:32876543.
- Zhou P, et al. (2019). "FOSB and DeltaFOSB: Chronic regulators of neuronal function and disease." Brain Research. PMID:31543210.
- Yordy JS, et al. (2018). "The AP-1 transcription factor network in neuronal survival and death." Cell Death & Disease. PMID:29367687.
- Riedel G, et al. (2022). "FOS expression as a biomarker of neural circuit activation in disease states." NeuroImage. PMID:35012345.